 |
|
|
 |
Anthrax Information From The Control Of Communicable Diseases Manual
Initial symptoms of inhalation anthrax are mild and nonspecific and may include fever, malaise and mild cough or chest pain; acute symptoms of respiratory distress, x-ray evidence of mediastinal widening, fever and shock follow in 3-5 days, with death shortly thereafter. Intestinal anthrax is rare and more difficult to recognize, except that it tends to occur in explosive food poisoning outbreaks; abdominal distress is followed by fever, signs of septicemia and death in the typical case. more
|
|
Los Angeles County: Bioterrorism Syndromes Poster
Los Angeles County, California, developed this poster to help first responders act in a bioterror emergency. Download and use it as an example in the development of your own materials. more
|
|
|
|
Information For The General Public: Guidance On Anthrax
The general public asks questions and receives answers in this short handout developed by the World Health Organization. Questions range from the types of illness caused by bacillus anthracis to how to handle suspicous mail. more
|
|
Fact Sheet: Anthrax
Anthrax is primarily a disease of herbivorous mammals, although other mammals and some birds have been known to contract it. Humans generally acquire the disease directly or indirectly from infected animals, or occupational exposure to infected or contaminated animal products. Control in livestock is therefore the key to reduced incidence. There are no documented cases of person to person transmission. more
|
|
Clinical Study: Plasmapheresis Of Anthrax-Vaccinated Subjects For Production Of Anthrax Immune Globulin
This protocol is a joint project of the National Institutes of Health, the Centers for Disease Control and the United States Army Medical Research Institute for Infectious Diseases. It is designed to collect plasma from healthy employees of the Department of Defense who have been vaccinated against anthrax. The collected plasma will be pooled to make an anthrax-fighting antibody solution called anthrax immune globulin intravenous (AIGIV). more
|
|
|
